Navigation Links
Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
Date:9/28/2007

- Renowned physicians provide viewers with important information on the use of aspirin in the prevention of initial and subsequent heart attacks and

strokes -

SILVER SPRING, Md., Sept. 28 /PRNewswire/ -- Discovery Health CME presents an expert discussion on aspirin and its use in the primary and secondary prevention of cardiovascular and cerebral-vascular events. Premiering Sunday, September 30, at 9 AM (ET/PT) on Discovery Health, ASPIRIN THERAPY: MAXIMIZING THE BENEFITS provides viewers with the latest on the benefits and the risks of this widely available medicine.

"There are good data regarding the use of aspirin in the prevention of vascular events," says John Whyte, M.D., M.P.H., vice president of CME, Discovery Health. "Yet despite these data, aspirin continues to be underutilized in patients who are at risk of initial or repeat heart attacks and strokes," he adds.

Many national organizations, including the American Heart Association, the American College of Cardiology and the American Diabetes Association, recommend aspirin therapy for patients at risk of heart attack and stroke, and the National Quality Forum and the Joint Commission on Accreditation of Healthcare Organizations use "aspirin for the prevention of cardiovascular events" as a quality measure. Even so, recent surveys demonstrate that many appropriate patients don't receive it.

Evidence presented in the program will demonstrate that when used appropriately, aspirin can prevent 32 percent of new myocardial infarctions and 15 percent of all vascular events. Additionally, the medicine can prevent a third of all repeat heart attacks, a quarter of repeat strokes and one-sixth of all vascular deaths. The risks of aspirin use, including gastrointestinal bleeding and aspirin resistance, are discussed as well.

In addition to the clinical benefits, the program details the significant pharmacoeconomic advantages associated with widespre
'/>"/>

SOURCE Discovery Health CME
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. OHSU Researchers Announce New Discovery
2. Discovery of bone gene
3. Latest discovery on Autism
4. Bacterial discovery may help CF patients
5. A new discovery about Acetaminophen
6. A new discovery about Acetaminophen
7. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
8. Treatment for cholesterol-related illnesses likely with the discovery of receptor in mice
9. Ways to counter radiation effects with new molecule discovery
10. Canada stunned as mad cow discovery leads to beef ban
11. Mouth Infection better handled with new discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... 19, 2013 Farming methods have changed ... the ground 10,000 years ago. Most recently, the Green ... by using genetically engineered seeds and by applying chemical ... backlash to these techniques due to the adverse environmental ... a corresponding surge in interest in organic, sustainable farming ...
(Date:5/19/2013)... WA (PRWEB) May 19, 2013 The Fat ... weight loss secrets that help people get in ... gender, and body shape. The program also is a natural ... diet plans. Besides, the author of this fat loss diet ... transformation program, which can help people keep body fat off ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Yeast infections are ... appear in sensitive areas of the human body. A new ... This new formula provides a unique method of application to ... spray solution is now provided to men and women searching ... naturally absorbed in the body through food and is stored ...
(Date:5/19/2013)... 19, 2013 Exciting new Skin Brushes ... reintroducing a great practice known through the ages but ... as dry body brushing, has so many benefits for ... Sublime Beauty®. "We love that circulation and lymphatic systems ... organ, the skin, is supported through Skin Brushing." , ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2
... at Weill Cornell Medical College could prove a potent weapon ... called SS31, is able to cross the blood-brain barrier and ... damage. ,"In our experiments, we found that exposing ... a much smaller area of brain tissue being affected," says ...
... (WHO) has approved four new drugs manufactured by the Macleods ... one of the four would be used against some strains ... of these four medicines will reinforce efforts to scale up ... in a statement. ,The medicines are the first ...
... out that organically grown kiwifruit has more health benefits ... This study is reported in the SCI’s magazine Chemistry ... in January that consuming organic fruits was just a ... by Drs. Maria Amodio and Adel Kader, showed that ...
... up 21 community medical centres in 20 provinces. This is ... run by the state, many of which are overflowing with ... is also intended to bring improvements to medical services in ... has said that 13 centres will be built in the ...
... independent survey which was conducted in all mental health ... continue to remain in mixed wards//. This is much ... in 99% of hospitals. ,The healthcare commission ... sleeping accommodation or bathrooms with the opposite sex. This ...
... fatty acids docosahexaenoic acid (DHA) successfully reduced diastolic blood ... up previous results with higher doses. // ,"A ... likely to be of clinical significance with regard to ... lead author Hannah Theobald from King's College London. ...
Cached Medicine News:Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:organic kiwifruits promote health 2Health News:Hospital Projects to Take the Weight Off Overcrowded Ones 2Health News:Low-dose Omega-3 Linked to Lower Blood Pressure 2
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... III study will evaluate effects of otelixizumab, an investigational anti-CD3 ... ... secretion, CAMBRIDGE, Mass., April 9, 2008 ... development of novel,therapies for immune-mediated diseases, today announced that it is,proceeding ...
... Calif., April 9, 2008 ,Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced that data from a Phase 2 ... patients with small,cell lung cancer (SCLC) will be ... Lung Cancer Conference in Geneva, Switzerland. The presentation ...
Cached Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 2Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 3
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
This large orifice 1000 ul tips is the large volume alternative to MBP's 200G tip. Pipet fragile cells, viscous samples and genomic DNA with ease....
Medicine Products: